Original Articles
Copyright ©The Author(s) 1999.
World J Gastroenterol. Jun 15, 1999; 5(3): 228-230
Published online Jun 15, 1999. doi: 10.3748/wjg.v5.i3.228
Table 1 Apolipoprotein E phenotype distributions and allele frequenc ies in patients with gallstones and controls
GroupsnPhenotype
Allele
E2/3(%)E2/4(%)E3/3(%)E3/4(%)ε2(%)ε3(%)ε4(%)
Patients8710(11.4)069(79.4)8(9.2)5.889.64.6
Male394(10.2)031(79.4)4(10.2)5.189.85.1
Female486(12.5)038(79.1)4(8.9)6.389.64.2
Controls505(10.0)2(4.0)37(74.1)6(12.0)7.085.08.0
Male273(10.0)1(3.7)20(74.0)3(11.0)7.485.27.4
Female232(8.6)1(4.3)17(74.6)3(13.0)6.584.88.7
Table 2 Comparisons of lipid levels in E2/2, E3/3, E3/4 both gallstone patients and controls
Lipids (mmol/L)E2/3
E3/3
E3/4
Patients (n = 10)Controls (n = 5)Patients (n = 69)Controls (n = 37)Patients (n = 8)Controls (n = 6)
TG1.43 ± 0.35a1.06 ± 0.100.97 ± 0.210.64 ± 0.441.11 ± 0.330.92 ± 0.16
TC2.99 ± 0.652.52 ± 0.533.14 ± 0.593.67 ± 0.763.94 ± 0.453.62 ± 0.63
LDL-C1.41 ± 0.56a2.04 ± 0.161.87 ± 0.492.43 ± 0.671.92 ± 0.642.46 ± 0.32
VLDL-C0.68 ± 0.26a0.48 ± 0.200.46 ± 0.200.30 ± 0.110.42 ± 0.130.44 ± 0.10
HDL-C0.95 ± 0.231.02 ± 0.150.89 ± 0.30a1.28 ± 0.230.86 ± 0.210.90 ± 0.36
HDL2-C0.53 ± 0.130.62 ± 0.220.49 ± 0.18b0.73 ± 0.130.44 ± 0.190.55 ± 0.18
HDL3-C0.42 ± 0.120.56 ± 0.280.39 ± 0.12b0.55 ± 0.110.40 ± 0.130.46 ± 0.12
Table 3 The comparisons of lipid levels in E3/3 same gender ei ther gallstone patients or controls
Lipids (mmol/L)Male
Female
Patients (n = 31)Controls (n = 20)Patients (n = 38)Controls (n = 17)
TG0.85 ± 0.500.53 ± 0.221.10 ± 0.300.72 ± 0.57
TC3.05 ± 0.440.41 ± 0.573.23 ± 0.853.87 ± 0.63
LDL-C1.86 ± 0.682.71 ± 0.491.89 ± 0.862.20 ± 0.56
VLDL-C0.40 ± 0.240.25 ± 0.100.52 ± 0.140.35 ± 0.17
HDL-C0.94 ± 0.331.21 ± 0.280.82 ± 0.27b1.33 ± 0.19
HDL2-C0.52 ± 0.220.69 ± 0.160.46 ± 0.15b0.77 ± 0.10
HDL3-C0.42 ± 0.120.52 ± 0.130.36 ± 0.12b0.57 ± 0.10